Dyne Therapeutics, Inc. (Nasdaq: DYN), a clinical-stage company focused on advancing life-transforming therapeutics for people living with genetically driven neuromuscular diseases, today announced ...

Mark Esser, PhD, was appointed the inaugural chief scientific officer and head of the upcoming Paul and Diane Manning Institute of Biotechnology at Charlottesville-based University of Virginia. In his ...

Sutter Health has named Dr. Matthew Solomon as its first chief scientific officer, a new executive role designed to integrate scientific research into patient care across the Sacramento-based ...

SunHydrogen, Inc. (OTC: HYSR) is pleased to announce the promotion of Dr. Syed Mubeen to the position of Chief Technology Officer (CTO) and the appointment of Hans-Peter Klein as Business Operations ...

Sports medicine specialist Casey Batten, MD, has been appointed chief medical officer of the 2028 Olympic and Paralympic ...

Dr Casey G. Batten, a sports medicine expert, will lead medical services at LA28. Cedars-Sinai, his affiliated institution, ...

“On behalf of everyone at Cytosurge and the entire Board, we’re thrilled to welcome Magid as we accelerate our commercial expansion ,” says Simon Egli, CEO of Cytosurge. His leadership and commercial ...

AscellaHealth, a global partner delivering customizable solutions to support the specialty pharmaceutical industry, today announces the promotion of Donovan Quill to chief strategy officer, Life ...

Industry leader in the development and application of cellular therapies, including CAR NK products, for cancer Led ...

High Force Research, a leading provider of specialist chemical R&D and manufacturing services, has announced the appointment of Dr Nathalie Huther as its new Chief Commercial Officer (CCO). This ...